Insider Monkey • 2 months ago
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
Capital Cube • 9 months ago
Click here to see latest analysisBio-Path Holdings, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -1.87 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.BPTH-US‘s earnings and EBITDA are […] (Read more...) The post Bio-Path Holdings, Inc. :BPTH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.
Zacks • 10 months ago
With the Q1 cycle nearing its end, the earnings picture is becoming increasingly clear. While the going looked tough at the onset of the last month, that scenario has changed over the past few weeks.
BPTH : Summary for Bio-Path Holdings, Inc. - Yahoo Finance
Bio-Path Holdings, Inc. (BPTH)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.84 - 0.87|
|52 Week Range||0.81 - 3.19|
|PE Ratio (TTM)||-11.32|
|Earnings Date||Mar 14, 2017 - Mar 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||3.25|